LEADER 02361nam a22005895i 4500
001 828465
003 TR_AnAIT
005 20260131055736
007 cr nn 008mamaa
008 151028s2013 xxk| s |||| 0|eng d
020 |a9781137349477|9978-1-137-34947-7
024 7 |a10.1057/9781137349477|2doi
041 |aeng
049 |aTürk Tarih Kurumu Kütüphanesi
050 4|aRM300-666
072 7|aMMG|2bicssc
072 7|aMED071000|2bisacsh
072 7|aMKG|2thema
082 04|a615|223
090 |aDK/29564
100 1 |aDavis, C.|eauthor.|4aut|4http://id.loc.gov/vocabulary/relators/aut
245 10|aUnhealthy Pharmaceutical Regulation|h[electronic resource] :|bInnovation, Politics and Promissory Science /|cby C. Davis, J. Abraham.
250 |a1st ed. 2013.
264 1|aLondon :|bPalgrave Macmillan UK :|bImprint: Palgrave Macmillan,|c2013.
300 |aXII, 321 p.|bonline resource.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
347 |atext file|bPDF|2rda
490 1 |aHealth, Technology and Society,|x2946-3378
520 |aThis is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.
650 0|aPharmacology.
650 0|aSocial medicine.
650 0|aSocial policy.
650 0|aPolitical sociology.
650 0|aPublic health.
650 0|aPharmaceutical chemistry.
650 14|aPharmacology.
650 24|aMedical Sociology.
650 24|aSocial Policy.
650 24|aPolitical Sociology.
650 24|aPublic Health.
650 24|aPharmaceutics.
700 1 |aAbraham, J.|eauthor.|4aut|4http://id.loc.gov/vocabulary/relators/aut
710 2 |aSpringerLink (Online service)
773 0 |tSpringer Nature eBook
776 08|iPrinted edition:|z9780230008663
776 08|iPrinted edition:|z9781349284160
776 08|iPrinted edition:|z9781349284177
830 0|aHealth, Technology and Society,|x2946-3378
856 40|uhttps://doi.org/10.1057/9781137349477
912 |aZDB-2-PSE
912 |aZDB-2-SXS
950 |aPalgrave Social Sciences Collection (SpringerNature-41146)
950 |aSocial Sciences (R0) (SpringerNature-43726)